Evidence map›Paper›PMID 42653970›Full record

ReviewMolecules (Basel, Switzerland)2026

From "Undetectable" to "Sensitive Detection": Advances in Derivatization Techniques for LC-MS Analysis of Genotoxic Impurities.

Xingchen Wang, Zhuzi Chen, Shunli Ji

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xingchen WangCollege of Food and Biotechnology, Wuhu Vocational Technical University, Wuhu 241000, China.
Zhuzi ChenOffice of Scientific Research, Jiangsu Health Vocational College, Nanjing 211800, China.
Shunli JiDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China.

Funding

the Natural Science Research Project of Universities in Anhui Province No. 2023AH052394the Project of Jiangsu Health Vocational College JKC202401the Scientific Research Project of Jiangsu Provincial Health Commission M2024058
6 · The paper itself

Abstract

Many genotoxic impurities (GTIs) remain "invisible" to conventional LC-MS due to poor ionization or chemical instability under electrospray ionization, yet their sub-ppm acceptable intake limits under ICH M7(R2) demand exceptional analytical sensitivity. Derivatization-the chemical introduction of ionizable moieties, stable tags, or MS/MS information carriers-offers a powerful strategy to overcome this limitation. This review provides a critical systematic overview of derivatization techniques for LC-MS analysis of GTIs over the past decade (2015-2025, based on a literature search across PubMed, Web of Science, and Scopus). We construct a functional-group-based strategic framework covering alkyl halides, nitroaromatics, sulfonyl chlorides, hydroxylamine, alcohols, aldehydes, carboxylic acids, and amines, while placing specific emphasis on typical impurities within these classes such as methyl iodide, methyl chloride, nitrobenzene, and benzenesulfonyl chloride, and discuss the evolution of reagents from simple "reaction tags" to "MS/MS information carriers" that provide characteristic neutral losses or product ions for enhanced selectivity. Quantitative analysis reveals that derivatization typically enhances ESI response by 2-3 orders of magnitude, consistently achieving LODs below 1 ppm-the ICH M7(R2) threshold. Key analytical trade-offs are critically evaluated, including the balance between derivatization efficiency and reaction time, by-product management, and the fundamental kinetic and chromatographic constraints that render post-column derivatization impractical for most GTIs. We conclude with perspectives on high-throughput automation, smart multifunctional reagents, online integration, and green chemistry, aiming to provide a practical roadmap for developing robust, sensitive, and regulatory-compliant LC-MS methods for GTI control.

Indexed as

Drug ContaminationLiquid Chromatography-Mass SpectrometryMutagensTandem Mass SpectrometryChromatography, LiquidMutagensderivatizationgenotoxic impuritiesICH M7LC-MS/MSsample pretreatment

Identifiers

PMID42653970
PMCPMC13515785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.